PrEP Effective Only When Drugs Taken As Prescribed, Study Shows

Humanosphere: HIV prevention trial exposes adherence challenge
Humanosphere reporter Tom Murphy discusses results of a study published recently in the New England Journal of Medicine examining the effectiveness of pre-exposure prophylaxis (PrEP) to prevent HIV infection. “Treatments to prevent the spread of HIV are extremely effective, only when people take them correctly. … The study, conducted in sub-Saharan Africa, is a small set-back for the potential of [PrEP] to prevent the spread of HIV/AIDS…” (2/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.